Allander Biotechnologies is a research and development-focused biotech company that aims to address unmet medical needs related to excessive inflammation and tissue regeneration defects. The company is developing proprietary biologics that exhibit regeneration and anti-inflammatory activities, with a particular emphasis on local and topical delivery methods. Their scientific approach has been validated through multiple in vitro and in vivo models, demonstrating the potential effectiveness of their solutions in treating various medical conditions.

The company's pipeline includes a range of products currently in development, supported by an extensive global patent portfolio. Allander Biotechnologies has successfully advanced its research from initial feasibility tests to drug development, indicating a clear regulatory pathway for their innovations. Additionally, the company has the capability to secure non-dilutive funding and attract equity investment, positioning itself as a significant player in the biotech industry focused on innovative therapies for tissue regeneration and inflammation-related disorders.

United States

Allander biotechnologies is a biotech company at the R&D stage focusing on drug development for unmet medical needs in tissue regeneration.

Allander Biotechnologies

Company Details